Australian Natural Therapeutics Group is a GMP, GACP certified producer of exclusive, pharmaceutical-grade medicinal cannabis products for patients worldwide.
ANTG produces exclusive high-quality cannabinoid based medicinal treatments to meet individual patient needs. It combines a strong research focus with best-in-class cultivation and extraction methods. Led by a board of skilled commercial leaders, the ANTG team includes experienced horticulturists, scientific researchers and medical advisors.
ANTG’s passion for the plant underpins its focus on putting the needs of patients first – and, as an independent company, it believes it is uniquely positioned to achieve more and be more for the benefit of humanity.
BOD Australia is a CBD and Hemp healthcare company.
By leading the way in research and development, the mission of BOD Australia is to innovate and transform the way we live and enjoy life through the delivery of premium, proven and trusted global products for both the consumer and healthcare professional.
Inspired from its work in research, clinical trials and partnerships, BOD Australia is building a suite of products across a range of indications within the healthcare industry.
BOD Australia’s pharmaceutical-grade, medicinal cannabis is now available in the UK and Australia with new markets now being opened around the globe.
Medifarm Tikun has changed its name to Tikun Australia, but remains proudly 100% Australian.
Tikun Australia is proud to partner with Tikun Olam, pioneers and world leaders in medicinal cannabis, to provide Australian patients with the most advanced medical cannabis treatments, supported by global research into plant science, manufacturing, and therapeutic outcome
Tikun Australia has an outstanding team who bring with them knowledge and experience, across a multitude of departments and are passionate about what they do.
Cannatrek was founded in 2015 and by 2017, had been awarded the second cannabis research licence to begin its journey to provide a better quality of life to Australian patients.
Cannatrek is a technology driven Australian company specialising in research, cultivation, manufacturing and delivery of medical cannabis. Its mission is to provide affordable care through its unique ‘seed to patient’ model.
Cannatrek aims to improve the accessibility of medicinal cannabis through lower prices, easier access and better education for patients and doctors.
Beacon Medical Australia is a wholly-owned subsidiary of VIVO Cannabis. Indoor, small batch, GMP production facilities produce premium quality, consistent products with strict standards including craft-like conditions, specially curated genetics and NO pesticides. Its mission is to advance patient care with innovative cannabinoid-based therapeutic products, developed to support and fulfil individuals unique health needs.
iX Syrinx is an expanding global company that is dedicated to improving health outcomes for its clients.
iX Syrinx is a fully integrated business providing end-to-end product development and manufacturing services for pharmaceutical and nutraceutical products.
Its scientists combine formulation know-how and oral, topical or sublingual delivery technologies to create unique and innovative solutions for pharmaceutical use and consumer health.
MedTEC Pharma was founded to lead the medicinal cannabis industry on a path to delivering an evidence-based medicine; trusted by health professionals and accessible by those needing relief from chronic conditions.
MedTEC Pharma is committed to delivering world-leading, bred-for-purpose medicinal cannabis. Its pathway to this objective includes partnerships with some of the leading research institutions in Australia and the world.
Scitek is the only ANZ based specialist cannabis manufacturing equipment supplier.
Its focus is on providing honest instrument selection advice, combined with benchmark service.
Scitek exclusively represents top brands, which have been picked for outstanding product features and demonstrated product quality.
Unlike the vast majority of laboratory instrumentation providers, the team at Scitek has more service engineers and application scientists than salespeople.
Cymra Life Sciences is an Australian-owned licenced cultivator and manufacturer of medical cannabis.
Cymra Life Sciences has two clear goals:
Cymra Life Sciences is the only cannabis company in Australia focusing on genetic development and supply to cannabis cultivators.
Spectrum Therapeutics, the medical division of Canopy Growth Corporation, is a biopharmaceutical company that develops innovative cannabis-based products to create effective formulations and delivery mechanisms, and to research their therapeutic effects.
Spectrum Therapeuticsis driven by a strong focus on quality, evidence, safety and education to deliver innovative medicines that raise the bar on therapy and outcomes for patients everywhere.
United in Compassion is Australia’s peak medicinal cannabis advocacy body founded in 2014 by Lucy Haslam and her late son Dan who benefited dramatically from medicinal cannabis during his battle with cancer.
Though he passed away in 2015, Dan's legacy lives on through the 2016 legislative changes making lawful cultivation of the plant for medical and research purposes possible.
The Country Women’s Association of Australia (CWAA) was formed in 1945 to provide a single voice to the Federal Government on behalf of the individual State and Territory Associations.
Its objective is to advance the rights and equity of women, families and communities in Australia through advocacy and empowerment, especially for those living in regional, rural and remote Australia.
The founder of United in Compassion, the leading NGO for medicinal cannabis, Lucy Haslam is also a founding member, Board Director and Chair of AMCA.
Passionate about access and affordability for patients, Lucy registered UIC (https://unitedincompassion.com.au/), as a member organisation of AMCA as soon as it was formed, and will work through both associations to advocate for, and further the interests of, patients in need.
Lucy continues to campaign tirelessly and, as well as organising the 2021 UIC Symposium being held from August 13-15 2021 at the Sunshine Coast, she has also been instrumental in driving the development of the online Australian Medicinal Cannabis Course For Health Professionals which has just launched (https://medicalcannabiscourse.com.au)
We are currently welcoming other organisations to become members to help us to shape the future of our industry for the benefit of the sector and the patients and carers that it serves.
Jodie was the first person to sign up for individual membership on the day that AMCA launched - 15th July 2020
Jodie is, in her own words, a "huge advocate for medicinal cannabis". As well as being a member of United in Compassion, Jodie is Federal Education Officer of the Australian Nursing and Midwifery Federation and has been charged with developing a conference (post-Covid 19) for nurses and midwives about Medicinal Cannabis. She has also written an education piece for nurses and midwives which is available on the online education portal (http://anmf.org.au/education).
We look forward to welcoming many more individuals to join AMCA and its member organisations to make this unique treatment more accessible and affordable. for patients.